deltatrials
Recruiting NA NCT06729684

Development and Validation of a Personalized Digital Healthcare Model for Managing Side Effects in Breast Cancer Survivors

Development and Validation of Personalized Digital Healthcare Technology and Service Model for the Management and Recovery of Side Effects of Treatment in Breast Cancer Survivors

Sponsor: Pusan National University Yangsan Hospital

Conditions Breast Cancer Breast Cancer Survivorship Digital Health
Interventions digital health (application and smartwatch)
Updated 2 times since 2025 Last updated: Dec 9, 2024 Started: Nov 13, 2024 Primary completion: May 31, 2025 Completion: May 31, 2025

This NA trial investigates Breast Cancer and Breast Cancer Survivorship and is currently actively recruiting participants. Pusan National University Yangsan Hospital leads this study, which shows 2 recorded versions since 2024 — indicating limited longitudinal coverage. As an oncology study, it adds to the longitudinal record of treatment development for this indication.

Change History

2 versions recorded

  1. Sep 2025 — Present [monthly]

    Recruiting NA

  2. Jan 2025 — Sep 2025 [monthly]

    Recruiting NA

    First recorded

Nov 2024

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Pusan National University Yangsan Hospital
  • Samsung Medical Center
Data source: Samsung Medical Center

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

  • • Seoul, South Korea